Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vivaldi Biosciences logo — Developing nasal-spray, self-adjuvanting vaccines: DeltaFLU...

Vivaldi Biosciences

Developing nasal-spray, self-adjuvanting vaccines: DeltaFLU universal flu vaccine, and Delta-19 universal flu + Covid-19

Founded 2006 United States Fort Collins, United States 11 employees Series Unknown Total: $26.97M Biotechnology

General Information

Company Name Vivaldi Biosciences
Founded Year 2006
Location United States Fort Collins, United States +2
Employees 11
Industries Biotechnology
Funding Stage Series Unknown
Social

Get notified when Vivaldi Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vivaldi Biosciences

Vivaldi Biosciences is a biotechnology company that was founded in 2006. The company received a $1.97M Venture Round investment on 08 July 2010. This investment marked a significant milestone for the company and served to propel its growth and development within the biotechnology industry. As the company continues to advance its innovative technologies and solutions, this investment underscores the confidence that investors have in Vivaldi Biosciences and its potential to make a meaningful impact in the biotechnology sector.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 08 Jul 2010
Series A •••••• 2
Investor Investor
21 Jan 2009
Series A •••••• 1
Investor
18 May 2007

Vivaldi Biosciences Alternatives & Competitors

Vivaldi Biosciences vs
Osivax
Osivax France

Pioneering A New Class of Universal Vaccines

Grant
53 employees
Biotechnology, Health Care
Compare Vivaldi Biosciences vs Osivax
Vivaldi Biosciences vs
Codagenix Inc.
Codagenix Inc. United States

Design Platform for Vaccine & Oncolytic Virus development ~ COVID, Flu, RSV, Dengue, YF / Breast Can...

Grant
19 employees
Biotechnology
Vivaldi Biosciences vs
Greffex, Inc.
Greffex, Inc. United States

Fast, safe, and cost-effective vaccine and gene therapy products made using our proprietary Universa...

15 employees
Biotechnology

FAQ About Vivaldi Biosciences

Developing nasal-spray, self-adjuvanting vaccines: DeltaFLU universal flu vaccine, and Delta-19 universal flu + Covid-19
Vivaldi Biosciences was founded in 2006.
Vivaldi Biosciences is headquartered in Fort Collins, United States.
Vivaldi Biosciences operates in the following industries: Biotechnology.
Vivaldi Biosciences has approximately 11 employees.
Vivaldi Biosciences has completed 3 funding rounds, raising a total of $26.97M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Vivaldi Biosciences include Osivax, Codagenix Inc., Greffex, Inc., SINOVAC BIOTECH LTD., EMERGEX VACCINES LTD. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vivaldi Biosciences and Osivax are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vivaldi Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy